부산대학교 도서관

Platt JR; Division of Oncology, Leeds Institute of Medical Research at St. James's, School of Medicine, University of Leeds, Leeds, LS2 9JT, United Kingdom.; Elliott F; Division of Haematology and Immunology, Leeds Institute of Medical Research at St. James's, School of Medicine, University of Leeds, Leeds, LS2 9JT, United Kingdom.; Handley K; Birmingham Clinical Trials Unit (BCTU), College of Medicine and Health, University of Birmingham, Birmingham, B15 2TT, United Kingdom.; Magill L; Birmingham Clinical Trials Unit (BCTU), College of Medicine and Health, University of Birmingham, Birmingham, B15 2TT, United Kingdom.; Quirke P; Division of Pathology & Data Analytics, Leeds Institute of Medical Research at St. James's, School of Medicine, University of Leeds, Leeds, LS2 9JT, United Kingdom.; Seymour MT; Division of Oncology, Leeds Institute of Medical Research at St. James's, School of Medicine, University of Leeds, Leeds, LS2 9JT, United Kingdom.; West NP; Division of Pathology & Data Analytics, Leeds Institute of Medical Research at St. James's, School of Medicine, University of Leeds, Leeds, LS2 9JT, United Kingdom.; Morton D; Institute of Applied Health Research, College of Medicine and Health, University of Birmingham, Birmingham, B15 2TT, United Kingdom.; Seligmann J; Division of Oncology, Leeds Institute of Medical Research at St. James's, School of Medicine, University of Leeds, Leeds, LS2 9JT, United Kingdom.; Tolan DJM; Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, LS9 7TF, United Kingdom.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0373125 Publication Model: Print Cited Medium: Internet ISSN: 1748-880X (Electronic) Linking ISSN: 00071285 NLM ISO Abbreviation: Br J Radiol Subsets: MEDLINE

Maughan TS; James RD; Kerr DJ; Ledermann JA; Seymour MT; Topham C; McArdle C; Cain D; Stephens RJ; Medical Research Council Colorectal Cancer Group (CORPORATE AUTHOR); Maughan, T S; James, R D; Kerr, D J; Ledermann, J A; Seymour, M T; Topham, C; McArdle, C; Cain, D; Stephens, R J

Lancet. 2/8/2003, Vol. 361 Issue 9356, p457-464. 8p.

Maughan TS; James RD; Kerr DJ; Ledermann JA; McArdle C; Seymour MT; Cohen D; Hopwood P; Johnston C; Stephens RJ; British MRC Colorectal Cancer Working Party (CORPORATE AUTHOR); Maughan, T S; James, R D; Kerr, D J; Ledermann, J A; McArdle, C; Seymour, M T; Cohen, D; Hopwood, P; Johnston, C

Lancet. 5/4/2002, Vol. 359 Issue 9317, p1555-1563. 9p.

Yin J; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.; Cohen R; Department of Medical Oncology, Saint-Antoine Hospital, Paris, France.; Jin Z; Department of Oncology, Mayo Clinic, Rochester, MN, USA.; Liu H; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.; Pederson L; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.; Adams R; Cardiff University and Velindre Cancer Centre, Cardiff, UK.; Grothey A; West Cancer Center and Research Institute, OneOncology, Germantown, TN, USA.; Maughan TS; CRUK/MRC Oxford Institute for Radiation Oncology, Oxford, UK.; St James's Hospital, University of Leeds, Leeds, UK.; Venook A; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Van Cutsem E; Digestive Oncology, University Hospitals Gasthuisberg Leuven, University of Leuven, Leuven, Belgium.; Punt C; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center, the Netherlands.; Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, the Netherlands.; Falcone A; Department of Oncology, University of Pisa, Pisa, Italy.; Tebbutt NC; Department of Medical Oncology, Austin Health, Melbourne, Australia.; Seymour MT; NIHR Clinical Research Network, St James's Hospital, University of Leeds, Leeds, UK.; Bokemeyer C; Department of Oncology, Haematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Rubio ED; Universidad Complutense Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos, Madrid, Spain.; Kaplan R; MRC Clinical Trials Unit at UCL, University College London, London, UK.; Heinemann V; University Hospital Grosshadern, Ludwig Maximilian University of Munich, Munich, Germany.; Chibaudel B; Institut Franco-Britannique, Levallois-Perret, France.; Yoshino T; National Cancer Center Hospital East, Tokyo, Japan.; Zalcberg J; School of Public Health and Preventative Medicine, Monash University, Melbourne, Australia.; Andre T; Hôpital Saint-Antoine, Paris, France.; De Gramont A; Department of Medical Oncology, Franco-British Institute, Levallois-Perret, France.; Shi Q; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.; Lenz HJ; Department of Gastrointestinal Oncology, Keck School of Medicine at USC, Los Angeles, CA, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

Williams CJM; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom.; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.; Elliott F; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.; Sapanara N; Medical & Scientific Affairs, Roche Molecular Systems Inc., Tucson, Arizona.; Aghaei F; Medical & Scientific Affairs, Roche Molecular Systems Inc., Tucson, Arizona.; Zhang L; Medical & Scientific Affairs, Roche Molecular Systems Inc., Tucson, Arizona.; Muranyi A; Medical & Scientific Affairs, Roche Molecular Systems Inc., Tucson, Arizona.; Yan D; Medical & Scientific Affairs, Roche Molecular Systems Inc., Tucson, Arizona.; Bai I; Medical & Scientific Affairs, Roche Molecular Systems Inc., Tucson, Arizona.; Zhao Z; Imaging and Algorithms, Digital Pathology, Roche Sequencing Solutions Inc., Santa Clara, California.; Shires M; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom.; Wood HM; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom.; Richman SD; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom.; Hemmings G; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom.; Hale M; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom.; Bottomley D; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom.; Galvin L; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom.; Cartlidge C; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom.; Dance S; Medical Affairs, Access and Innovation, Roche Diagnostics Limited, Burgess Hill, United Kingdom.; Bacon CM; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.; Mansfield L; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.; Young-Zvandasara K; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.; Sudan A; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.; Lambert K; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.; Bibby I; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.; Coupland SE; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.; Montazeri A; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom.; Kipling N; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.; Hughes K; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom.; Cross SS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom.; Dewdney A; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.; Pheasey L; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.; Leng C; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.; Gochera T; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.; Mangham DC; Adult Histopathology, Laboratory Medicine, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, United Kingdom.; Saunders M; The Christie NHS Foundation Trust, Manchester, United Kingdom.; Pritchard M; Adult Histopathology, Laboratory Medicine, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, United Kingdom.; Stott H; The Christie NHS Foundation Trust, Manchester, United Kingdom.; Mukherjee A; Translational Medical Sciences, Cancer and Stem Cells, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom.; Ilyas M; Translational Medical Sciences, Cancer and Stem Cells, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom.; Silverman R; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.; Hyland G; Translational Medical Sciences, Cancer and Stem Cells, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom.; Sculthorpe D; Translational Medical Sciences, Cancer and Stem Cells, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom.; Thornton K; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.; Gould I; Translational Medical Sciences, Cancer and Stem Cells, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, United Kingdom.; O'Callaghan A; Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom.; Brown N; Calderdale and Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom.; Turnbull S; Calderdale and Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom.; Shaw L; Calderdale and Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom.; Seymour MT; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.; West NP; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom.; Seligmann JF; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.; Singh S; Medical & Scientific Affairs, Roche Molecular Systems Inc., Tucson, Arizona.; Shanmugam K; Medical & Scientific Affairs, Roche Molecular Systems Inc., Tucson, Arizona.; Quirke P; Division of Pathology and Data Analytics, University of Leeds, Leeds, United Kingdom.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Lord SR; Hall PS; McShane P; Brown J; Seymour MT

Clinical Oncology. Mar2010, Vol. 22 Issue 2, p107-113. 7p.

Richman SD; Seymour MT; Chambers P; Elliott F; Daly CL; Meade AM; Taylor G; Barrett JH; Quirke P; Richman, Susan D; Seymour, Matthew T; Chambers, Philip; Elliott, Faye; Daly, Catherine L; Meade, Angela M; Taylor, Graham; Barrett, Jennifer H; Quirke, Philip

Journal of Clinical Oncology. 12/10/2009, Vol. 27 Issue 35, p5931-5937. 7p.

Braun MS; Richman SD; Thompson L; Daly CL; Meade AM; Adlard JW; Allan JM; Parmar MK; Quirke P; Seymour MT; Braun, Michael S; Richman, Susan D; Thompson, Lindsay; Daly, Catherine L; Meade, Angela M; Adlard, Julian W; Allan, James M; Parmar, Mahesh K B; Quirke, Philip; Seymour, Matthew T

Journal of Clinical Oncology. 11/20/2009, Vol. 27 Issue 33, p5519-5528. 10p.

Sargent DJ; Köhne CH; Sanoff HK; Bot BM; Seymour MT; de Gramont A; Porschen R; Saltz LB; Rougier P; Tournigand C; Douillard JY; Stephens RJ; Grothey A; Goldberg RM; Sargent, Daniel J; Köhne, Claus Henning; Sanoff, Hanna Kelly; Bot, Brian M; Seymour, Matthew T; de Gramont, Aimery

Journal of Clinical Oncology. 4/20/2009, Vol. 27 Issue 12, p1948-1955. 8p.

Hennig IM; Naik JD; Brown S; Szubert A; Anthoney DA; Jackson DP; Melcher AM; Crawford SM; Bradley C; Brown JM; Seymour MT

Journal of Clinical Oncology. 7/10/2008, Vol. 26 Issue 20, p3411-3417. 7p.

Braun MS; Richman SD; Quirke P; Daly C; Adlard JW; Elliott F; Barrett JH; Selby P; Meade AM; Stephens RJ; Parmar MK; Seymour MT; Braun, Michael S; Richman, Susan D; Quirke, Philip; Daly, Catherine; Adlard, Julian W; Elliott, Faye; Barrett, Jennifer H; Selby, Peter

Journal of Clinical Oncology. 6/1/2008, Vol. 26 Issue 16, p2690-2698. 9p.

Folprecht G; Seymour MT; Saltz L; Douillard JY; Hecker H; Stephens RJ; Maughan TS; Van Cutsem E; Rougier P; Mitry E; Schubert U; Köhne CH; Folprecht, Gunnar; Seymour, Matthew T; Saltz, Leonard; Douillard, Jean-Yves; Hecker, Hartmut; Stephens, Richard J; Maughan, Timothy S; Van Cutsem, Eric

Journal of Clinical Oncology. 3/20/2008, Vol. 26 Issue 9, p1443-1451. 9p.

Adlard JW; Richman SD; Seymour MT; Quirke P; Adlard, Julian W; Richman, Susan D; Seymour, Matthew T; Quirke, Phil

Lancet Oncology. Feb2002, Vol. 3 Issue 2, p75-82. 8p.

Burzykowski T; International Drug Development Institute, Louvain-la-Neuve, Belgium.; Hasselt University, Diepenbeek, Belgium.; Coart E; International Drug Development Institute, Louvain-la-Neuve, Belgium.; Saad ED; International Drug Development Institute, Louvain-la-Neuve, Belgium.; Shi Q; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.; Sommeijer DW; The University of Sydney, Camperdown, New South Wales, Australia.; Academic Medical Centre, Amsterdam, the Netherlands.; Flevohospital, Almere, the Netherlands.; Bokemeyer C; Department of Internal Medicine II and Clinic, University of Hamburg, Hamburg, Germany.; Díaz-Rubio E; Hospital Clinico San Carlos and Centro de Investigación Biomédica en Red Cáncer, CIBERONC, Madrid, Spain.; Douillard JY; Centre René Gauducheau, St Herblain, France.; Falcone A; University Hospital S Chiara, Pisa, Italy.; Fuchs CS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Goldberg RM; West Virginia University Cancer Institute, Morgantown.; Hecht JR; David Geffen School of Medicine, University of California, Los Angeles.; Hoff PM; Instituto de Câncer do Estado de São Paulo, São Paulo, Brazil.; Hurwitz H; Genentech, South San Francisco, California.; Kabbinavar FF; David Geffen School of Medicine, University of California, Los Angeles.; Koopman M; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.; Maughan TS; Cancer Research UK and the Medical Research Council Oxford Institute for Radiation Oncology, Oxford, United Kingdom.; Punt CJA; Amsterdam University Medical Centrum, Department of Medical Oncology, University of Amsterdam, Amsterdam, the Netherlands.; Saltz L; Memorial Sloan-Kettering Cancer Center, New York, New York.; Schmoll HJ; Martin-Luther University, Halle, Germany.; Seymour MT; St James's Hospital, University of Leeds, Leeds, United Kingdom.; Tebbutt NC; Austin Health, Heidelberg, Victoria, Australia.; Tournigand C; Hôpital Henri Mondor, Creteil, France.; Van Cutsem E; Division of Digestive Oncology, University Hospitals Gasthuisberg Leuven, Leuven, Belgium.; de Gramont A; Katholieke Universiteit, Leuven, Belgium.; Franco-British Institute, Levallois-Perret, France.; Zalcberg JR; School of Public Health and Preventative Medicine, Monash University, Melbourne, Australia.; Buyse M; Hasselt University, Diepenbeek, Belgium.; International Drug Development Institute Inc, San Francisco, California.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Kwakman JJM; a Department of Medical Oncology , Amsterdam UMC, University of Amsterdam , Amsterdam , The Netherlands.; van Kruijsdijk RCM; b Department of Internal Medicine , University Medical Center Utrecht, Utrecht University , Utrecht , The Netherlands.; Elias SG; c Department of Epidemiology , Julius Center for Health Sciences and Primary Care University Medical Center Utrecht, Utrecht University , Utrecht , The Netherlands.; Seymour MT; d Department of Medical Oncology , The Leeds Teaching Hospitals, University of Leeds , Leeds , UK.; Meade AM; e Clinical Trials Unit at UCL , Institute of Clinical Trials and Methodology , London , UK.; Visseren FLJ; f Department of Vascular Medicine , University Medical Center Utrecht, Utrecht University , Utrecht , The Netherlands.; Punt CJA; g Department of Medical Oncology , Amsterdam UMC, University of Amsterdam , Amsterdam , The Netherlands.; Koopman M; h Department of Medical Oncology , University Medical Center Utrecht, Utrecht University , Utrecht , The Netherlands.

Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE

Sjoquist KM; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.; Cancer Care Centre, St George Hospital, Kogarah, NSW, Australia.; Renfro LA; Mayo Clinic, Rochester, MN.; Simes RJ; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.; Tebbutt NC; Austin Health, Heidelberg, Victoria, Australia.; Clarke S; Royal North Shore Hospital, St Leonards, Australia.; Seymour MT; Cancer Research UK Clinical Centre, Leeds, UK.; Adams R; Cardiff University and Velindre Cancer Centre, Cardiff, UK.; Maughan TS; St James's Hospital and University of Leeds, Leeds, UK.; Saltz L; Memorial Sloan Kettering Cancer Center, New York, NY.; Goldberg RM; West Virginia University Cancer Institute, Morgantown, WV.; Schmoll HJ; Martin-Luther-University, Halle, Germany.; Van Cutsem E; University Hospital Leuven, Leuven, Belgium.; Douillard JY; European Society for Medical Oncology (ESMO) Chief Medical Officer (CMO), Institut de Cancérologie de l'Ouest (ICO) René Gauducheau, Saint-Herblain, France.; Hoff PM; Instituto do Cancer do Estado de Sao Paulo, Universidade de Sao Paolo, Sao Paolo, Brazil.; Hecht JR; David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA.; Tournigand C; University of Paris Est Creteil, Paris, France.; Assistance Hopitaux Publique de Paris Henri-Mondor Hospital, Creteil, France.; Punt CJA; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Koopman M; University Medical Center Utrecht, Utrecht University, the Netherlands.; Hurwitz H; Duke University Medical Center, Durham, NC.; Heinemann V; University of Munich, Department of Medical Oncology and Comprehensive Cancer Center, Munich, Germany.; Falcone A; Department of Oncology, University of Pisa, Pisa, Italy.; Porschen R; Klinikum Bremen-Ost Klinik fur Innere Medizin, Bremen, Germany.; Fuchs C; Dana-Farber Cancer Institute, Boston, MA.; Diaz-Rubio E; Department of Oncology, Hospital Clínico San Carlos, CIBERONC Instituto de Salud Carlos III, Madrid, Spain.; Aranda E; Department of Medical Oncology IMIBIC, Reina Sofía Hospital, University of Córdoba, CIBERONC Instituto de Salud Carlos III, Córdoba, Spain.; Bokemeyer C; University Hospital, Hamburg-Eppendorf, Germany.; Souglakos I; University of Crete, Heraklion, Greece.; Kabbinavar FF; David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA.; Chibaudel B; Franco-British Institute, Levallois-Perret, France.; Meyers JP; Mayo Clinic, Rochester, MN.; Sargent DJ; Mayo Clinic, Rochester, MN.; de Gramont A; Franco-British Institute, Levallois-Perret, France.; Zalcberg JR; School of Public Health and Preventative Medicine, Monash University, Melbourne, Australia.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst

Braun MS; Adab F; Bradley C; McAdam K; Thomas G; Wadd NJ; Rea D; Philips R; Twelves C; Bozzino J; MacMillan C; Saunders MP; Counsell R; Anderson H; McDonald A; Stewart J; Robinson A; Davies S; Richards FJ; Seymour MT

Br J Cancer

Seligmann JF; Institute of Clinical Trials Research, University of Leeds, Leeds, UK.; Seymour MT; Institute of Cancer and Pathology, University of Leeds, Leeds, UK.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

Hall PS; University of Leeds, Leeds, United Kingdom.; University of Edinburgh, Edinburgh, United Kingdom.; Cairns DA; University of Leeds, Leeds, United Kingdom.; Seymour MT; University of Leeds, Leeds, United Kingdom.; Leeds Teaching Hospitals NHS Trust, United Kingdom.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

Ten Hoorn S; Amsterdam UMC, University of Amsterdam, LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, Amsterdam, The Netherlands.; Sommeijer DW; Amsterdam UMC, University of Amsterdam, LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Flevohospital, Department of Internal Medicine, Almere, The Netherlands.; Elliott F; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, UK.; Fisher D; MRC Clinical Trials Unit, University College London, London, UK.; de Back TR; Amsterdam UMC, University of Amsterdam, LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, Amsterdam, The Netherlands.; Trinh A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Koens L; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Maughan T; Department of Oncology, University of Oxford, Oxford, UK.; Seligmann J; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, UK.; Seymour MT; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, UK.; Quirke P; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, UK.; Adams R; Centre for Trials Research Cardiff University and Velindre Hospital, Cardiff, Wales, UK.; Richman SD; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, UK.; Punt CJA; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht University, Utrecht, The Netherlands.; Vermeulen L; Amsterdam UMC, University of Amsterdam, LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands. l.vermeulen@amsterdamumc.nl.; Oncode Institute, Amsterdam UMC, Amsterdam, The Netherlands. l.vermeulen@amsterdamumc.nl.; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. l.vermeulen@amsterdamumc.nl.

Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE